Abstract

MYH9 was recently identified as renal susceptibility gene (OR 3–8, p<10−8) for major forms of kidney disease disproportionately affecting individuals of African descent. The risk haplotype (E-1) occurs at much higher frequencies in African Americans (≥60%) than in European Americans (<4%), revealing a genetic basis for a major health disparity. The population distributions of MYH9 risk alleles and the E-1 risk haplotype and the demographic and selective forces acting on the MYH9 region are not well explored. We reconstructed MYH9 haplotypes from 4 tagging single nucleotide polymorphisms (SNPs) spanning introns 12–23 using available data from HapMap Phase II, and by genotyping 938 DNAs from the Human Genome Diversity Panel (HGDP). The E-1 risk haplotype followed a cline, being most frequent within sub-Saharan African populations (range 50–80%), less frequent in populations from the Middle East (9–27%) and Europe (0–9%), and rare or absent in Asia, the Americas, and Oceania. The fixation indexes (FST) for pairwise comparisons between the risk haplotypes for continental populations were calculated for MYH9 haplotypes; FST ranged from 0.27–0.40 for Africa compared to other continental populations, possibly due to selection. Uniquely in Africa, the Yoruba population showed high frequency extended haplotype length around the core risk allele (C) compared to the alternative allele (T) at the same locus (rs4821481, iHs = 2.67), as well as high population differentiation (FST(CEU vs. YRI) = 0.51) in HapMap Phase II data, also observable only in the Yoruba population from HGDP (FST = 0.49), pointing to an instance of recent selection in the genomic region. The population-specific divergence in MYH9 risk allele frequencies among the world's populations may prove important in risk assessment and public health policies to mitigate the burden of kidney disease in vulnerable populations.

Highlights

  • A genome wide admixture linkage scan followed by fine mapping recently identified MYH9, encoding non-muscle myosin heavy chain IIA, as a major susceptibility locus for focal segmental glomerulosclerosis (FSGS), HIV-associated collapsing glomerulosclerosis, called HIV-associated nephropathy (HIVAN), and end stage kidney disease (ESKD) attributed to hypertension [1,2]

  • Is 18-fold or greater in African Americans compared to nonAfrican descent populations and it is estimated that the life-time risk of HIVAN among African Americans with HIV-1 disease, in the absence of anti-retroviral therapy, is 10% [6]

  • We present an analysis of the E haplotype block and tagging single nucleotide polymorphisms (SNPs) in a worldwide population survey of major continental populations using a compilation of data from the International HapMap Project and the Human Genome Diversity Panel (HGDP)

Read more

Summary

Introduction

A genome wide admixture linkage scan followed by fine mapping recently identified MYH9, encoding non-muscle myosin heavy chain IIA, as a major susceptibility locus for focal segmental glomerulosclerosis (FSGS), HIV-associated collapsing glomerulosclerosis, called HIV-associated nephropathy (HIVAN), and end stage kidney disease (ESKD) attributed to hypertension [1,2]. MYH9 provides a plausible genetic explanation for much of this disparity as the MYH9 alleles and the haplotype most strongly associated with kidney disease are highly frequent in African Americans (allele frequencies

Results and Discussion
Oceania
Materials and Methods
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call